Please assess the completion status of the following clinical trial:

Trial Title: A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Have completed the qualifying OB-202 trial~* If females of child-bearing potential, subjects must be using adequate contraception~* Provide written informed consent~* Be willing and able to comply with scheduled study visits, treatment plan, lab tests and other study procedures~Exclusion Criteria:~* Subjects who have developed one or more morbidities during the OB-202 trial that would pose a safety concern

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).